Background
Methods
Patients and tumor samples
IDH mutation
Gene set enrichment analysis
Statistical analysis
Results
Clinical and molecular characterization of IDH2 mutations
Pathological diagnosis | WHO grade |
n = 811 |
IDH1 mutation No. (%) |
IDH2 mutation No. (%) | IDH mutation total No. (%) |
---|---|---|---|---|---|
Diffuse astrocytoma | II | 193 | 138 (71.5) | 2 (1.0) | 140 (72.5) |
Anaplastic astrocytoma | III | 39 | 14 (35.9) | 0 (0) | 14 (35.9) |
Oligodendroglioma | II | 49 | 38 (77.6) | 3 (6.1) | 41 (83.7) |
Anaplastic oligodendroglioma | III | 27 | 19 (70.4) | 1 (3.7) | 20 (74.1) |
Oligoastrocytoma | II | 186 | 147 (79.0) | 9 (4.8) | 156 (83.8) |
Anaplastic oligoastrocytoma | III | 83 | 47 (56.6) | 1 (1.2) | 48 (57.8) |
Subtotal (grades II and III) | 577 | 403 (69.8) | 16 (2.8) | 419 (72.6) | |
Primary GBM | IV | 205 | 29 (14.1) | 1 (0.5) | 30 (14.6) |
Secondary GBM | IV | 29 | 16 (55.2) | 1 (3.4) | 17 (58.6) |
Subtotal (Glioblastoma) | IV | 234 | 45 (19.2) | 2 (0.9) | 47 (20.1) |
Total | 811 | 448 (55.2) | 18 (2.2) | 466 (57.4) |
Clinical characteristic |
N = 811 |
IDH1-Mutated |
IDH2-Mutated |
IDH1/IDH2-Wild-type |
P (IDH1-Mutated VS IDH1/IDH2- Wild-type) |
P (IDH2-Mutated VS IDH1/IDH2- Wild-type) |
P (IDH1-Mutated VS IDH2-Mutated) | |
---|---|---|---|---|---|---|---|---|
No. (%) | No. (%) | No. (%) | ||||||
Age, years | <45 | 423 | 285 (67.4) | 13 (3.1) | 125 (29.5) | <0.001 | <0.05 | 0.456 |
≥45 | 388 | 163 (42.0) | 5 (1.3) | 220 (56.7) | ||||
Median age, years | 39.1 | 37.3 | 45.0 | <0.001 | <0.05 | 0.456 | ||
Range | 17.0–66.0 | 26.0–56.0 | 9.0–81.0 | |||||
Gender | Male | 495 | 265 (53.5) | 11 (2.2) | 219 (44.2) | 0.113 | 0.801 | 0.824 |
Female | 316 | 186 (58.9) | 7 (2.2) | 123 (38.9) | ||||
WHO Grade | II + III | 577 | 403 (69.8) | 16 (2.8) | 158 (27.4) | <0.001 | <0.001 | 0.883 |
IV | 234 | 45 (19.2) | 2 (0.9) | 187 (79.9) | ||||
KPS score | <80 | 74 | 26 (35.1) | 2 (2.7) | 46 (62.2) | <0.001 | 0.376 | 0.514 |
≥80 | 253 | 173 (68.4) | 7 (2.8) | 73 (28.8) | ||||
NA | 483 | 248 | 9 | 226 | ||||
Histologic type | Oligodendroglioma | 76 | 57 (75.0) | 4 (5.3) | 15 (19.7) | <0.001 | <0.001 | 0.218 |
Oligoastrocytoma | 269 | 194 (72.1) | 10 (3.7) | 65 (24.2) | ||||
Astrocytoma | 437 | 181 (41.4) | 3 (0.7) | 253 (57.9) | ||||
sGBM | 29 | 16 (55.2) | 1 (3.4) | 12 (41.4) | ||||
Laterality | Left | 380 | 211 (55.5) | 9 (2.4) | 160 (42.1) | <0.05 | 0.891 | 0.985 |
Right | 366 | 203 (55.5) | 8 (2.2) | 155 (42.3) | ||||
Midline | 53 | 33 (62.3) | 1 (1.9) | 19 (35.8) | ||||
NA | 12 | 1 | 0 | 11 |
Molecular Characteristic |
IDH1-Mutated |
IDH2-Mutated |
IDH1/IDH2-WT | P (IDH1-Mutated VS IDH1/IDH2-WT) | P (IDH2-Mutated VS IDH1/IDH2-WT) | P (IDH1-Mutated VS IDH2-Mutated) | |
---|---|---|---|---|---|---|---|
PTEN
| Mutation | 6 | 0 | 43 | <0.001 | 0.098 | 0.605 |
Wild-type | 314 | 14 | 218 | ||||
NA | 128 | 4 | 84 | ||||
1p/19q Co-deletion | Absent | 341 | 9 | 307 | <0.001 | <0.001 | <0.05 |
Present | 106 | 9 | 34 | ||||
NA | 1 | 0 | 1 | ||||
P53
| Mutation | 215 | 0 | 232 | <0.001 | 0.154 | <0.05 |
Wild-type | 115 | 14 | 34 | ||||
NA | 118 | 4 | 79 | ||||
ATRX
| Mutation | 13 | 0 | 15 | 0.084 | 0.638 | 0.728 |
Wild-type | 107 | 5 | 102 | ||||
NA | 328 | 13 | 228 |